JP2021527046A5 - - Google Patents

Info

Publication number
JP2021527046A5
JP2021527046A5 JP2020567808A JP2020567808A JP2021527046A5 JP 2021527046 A5 JP2021527046 A5 JP 2021527046A5 JP 2020567808 A JP2020567808 A JP 2020567808A JP 2020567808 A JP2020567808 A JP 2020567808A JP 2021527046 A5 JP2021527046 A5 JP 2021527046A5
Authority
JP
Japan
Prior art keywords
alkylene
difluoromethoxy
isopropylphenyl
methylpyridine
azetidine
Prior art date
Application number
JP2020567808A
Other languages
English (en)
Japanese (ja)
Other versions
JP7386183B2 (ja
JP2021527046A (ja
JPWO2019234115A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/064690 external-priority patent/WO2019234115A1/en
Publication of JP2021527046A publication Critical patent/JP2021527046A/ja
Publication of JP2021527046A5 publication Critical patent/JP2021527046A5/ja
Publication of JPWO2019234115A5 publication Critical patent/JPWO2019234115A5/ja
Application granted granted Critical
Publication of JP7386183B2 publication Critical patent/JP7386183B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020567808A 2018-06-07 2019-06-05 Lpa1受容体アンタゴニストとしてのアルコキシ置換ピリジニル誘導体及び繊維症の治療におけるその使用 Active JP7386183B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2018/065016 2018-06-07
EP2018065016 2018-06-07
PCT/EP2019/064690 WO2019234115A1 (en) 2018-06-07 2019-06-05 Alkoxy-substituted pyridinyl derivatives as lpa1 receptor antagonists and their use in the treatment of fibrosis

Publications (4)

Publication Number Publication Date
JP2021527046A JP2021527046A (ja) 2021-10-11
JP2021527046A5 true JP2021527046A5 (https=) 2022-06-06
JPWO2019234115A5 JPWO2019234115A5 (https=) 2022-06-06
JP7386183B2 JP7386183B2 (ja) 2023-11-24

Family

ID=66912779

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020567808A Active JP7386183B2 (ja) 2018-06-07 2019-06-05 Lpa1受容体アンタゴニストとしてのアルコキシ置換ピリジニル誘導体及び繊維症の治療におけるその使用

Country Status (22)

Country Link
US (1) US12344597B2 (https=)
EP (1) EP3802517B1 (https=)
JP (1) JP7386183B2 (https=)
KR (1) KR102826034B1 (https=)
CN (1) CN112236424B (https=)
AU (1) AU2019282274A1 (https=)
BR (1) BR112020024879A2 (https=)
CA (1) CA3102683A1 (https=)
DK (1) DK3802517T3 (https=)
EA (1) EA202092955A1 (https=)
ES (1) ES2940695T3 (https=)
FI (1) FI3802517T3 (https=)
HR (1) HRP20230243T1 (https=)
HU (1) HUE061559T2 (https=)
LT (1) LT3802517T (https=)
MX (1) MX2020013291A (https=)
PL (1) PL3802517T3 (https=)
PT (1) PT3802517T (https=)
RS (1) RS63990B1 (https=)
SI (1) SI3802517T1 (https=)
TW (1) TW202016090A (https=)
WO (1) WO2019234115A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR119162A1 (es) * 2019-06-18 2021-12-01 Idorsia Pharmaceuticals Ltd Derivados de piridin-3-ilo
KR20220109439A (ko) 2019-12-04 2022-08-04 이도르시아 파마슈티컬스 리미티드 섬유증 질환의 치료에서 사용하기 위한 아제티딘 lpa1 수용체 길항제와 피르페니돈 및/또는 닌테다닙의 조합
FI20225388A1 (en) 2022-05-05 2023-11-06 Equinorm Ltd New heterocyclic compounds, preparation methods and their uses
WO2025169931A1 (ja) * 2024-02-05 2025-08-14 Ube株式会社 カルボキサミド化合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130088C (https=) 1960-03-14
GB9420763D0 (en) 1994-10-14 1994-11-30 Glaxo Inc Acetamide derivatives
GB9919776D0 (en) 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds
WO2001032173A1 (en) 1999-10-29 2001-05-10 Yamanouchi Pharmaceutical Co., Ltd. Kainic acid neurocytotoxicity inhibitors
AU2001262185A1 (en) 2000-04-10 2001-10-23 Novartis Ag Substituted (hetero)aryl carboxamide derivatives as microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) secretion
WO2002062389A1 (en) 2001-02-08 2002-08-15 Ono Pharmaceutical Co., Ltd. Remedies for urinary diseases comprising lpa receptor controlling agents
TW200403058A (en) * 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
US7435824B2 (en) 2002-04-19 2008-10-14 Bristol-Myers Squibb Company Prodrugs of potassium channel inhibitors
TW200505902A (en) 2003-03-20 2005-02-16 Schering Corp Cannabinoid receptor ligands
JP4847868B2 (ja) 2003-05-14 2011-12-28 ニューロジェネティック ファーマシューティカルズ、 インコーポレイテッド 化合物、及び、アミロイドベータの調節におけるその使用
US7749999B2 (en) 2003-09-11 2010-07-06 Itherx Pharmaceuticals, Inc. Alpha-ketoamides and derivatives thereof
EP1679069A4 (en) 2003-10-21 2009-05-13 Dainippon Sumitomo Pharma Co NEW PIPERIDINE DERIVATIVE
EP1687296A1 (en) 2003-11-18 2006-08-09 Warner-Lambert Company LLC Antibacterial aminoquinazolidinedione derivatives
WO2006091862A2 (en) 2005-02-24 2006-08-31 Kemia, Inc. Cytokine inhibitors and their use in therapy
HRP20130719T1 (en) 2005-08-24 2013-09-30 Eisai R&D Management Co., Ltd. Novel pyridine derivative and pyrimidine derivative (3)
WO2007058990A2 (en) 2005-11-14 2007-05-24 Kemia, Inc. Therapy using cytokine inhibitors
CA2691214A1 (en) 2006-06-09 2007-12-21 Kemia, Inc. Therapy using cytokine inhibitors
JP5164510B2 (ja) 2006-10-06 2013-03-21 日本曹達株式会社 含窒素複素環化合物および有害生物防除剤
WO2008115281A2 (en) 2006-10-16 2008-09-25 Myriad Genetics, Inc. Compounds for treating viral infections
ATE552257T1 (de) 2007-10-18 2012-04-15 Merck Sharp & Dohme Positive allosterische chinolizidinon-m1- rezeptormodulatoren
US8193202B2 (en) 2008-04-21 2012-06-05 Lexicon Pharmaceuticals, Inc. LIMK2 inhibitors, compositions comprising them, and methods of their use
RU2529484C2 (ru) 2008-05-05 2014-09-27 Санофи-Авентис Ациламино-замещенные производные конденсированных циклопентанкарбоновых кислот и их применение в качестве фармацевтических средств
MX2011001938A (es) 2008-08-26 2011-03-29 Boehringer Ingelheim Int Tienopirimidinas para composiciones farmaceuticas.
BR112012006686B8 (pt) * 2009-09-25 2021-05-25 Astellas Pharma Inc compostos de amida substituída, composições farmacêuticas contendo os ditos compostos, e uso dos mesmos para prevenir e/ou tratar doenças causadas pelo lpa
CN103270036B (zh) 2010-08-05 2015-11-25 佐蒂斯有限责任公司 作为抗寄生物剂的异噁唑啉衍生物
TW201305178A (zh) 2010-10-29 2013-02-01 Glenmark Pharmaceuticals Sa 作為mPGES-1抑制物的三環化合物
EP3360552A1 (en) 2010-12-07 2018-08-15 Amira Pharmaceuticals, Inc. Polycyclic lpa1 antagonist and uses thereof
US9073895B2 (en) 2010-12-16 2015-07-07 Boehringer Ingelheim International Gmbh Biarylamide inhibitors of leukotriene production
ME02412B (me) 2011-03-10 2016-09-20 Zoetis Services Llc Spirociklični derivati izoksazolina kao antiparazitska sredstva
JP2015506349A (ja) 2011-12-21 2015-03-02 アルデリックス, インコーポレイテッド 非全身性tgr5アゴニスト
US20140148484A1 (en) 2012-11-23 2014-05-29 Boehringer Ingelheim International Gmbh Pyrazole compounds for treating hairloss
TW201444820A (zh) * 2013-03-13 2014-12-01 Abbvie Inc 吡啶cdk9激酶抑制劑
AR108185A1 (es) 2016-04-06 2018-07-25 Abbvie Inc Amidas terciarias y método para su uso
AR119162A1 (es) 2019-06-18 2021-12-01 Idorsia Pharmaceuticals Ltd Derivados de piridin-3-ilo
KR20220109439A (ko) 2019-12-04 2022-08-04 이도르시아 파마슈티컬스 리미티드 섬유증 질환의 치료에서 사용하기 위한 아제티딘 lpa1 수용체 길항제와 피르페니돈 및/또는 닌테다닙의 조합

Similar Documents

Publication Publication Date Title
JP2021527046A5 (https=)
RU2021133444A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
CN116531380B (zh) 用于治疗癌症的2-杂芳基-3-氧代-2,3-二氢哒嗪-4-甲酰胺
FI3802517T3 (fi) Alkoksisubstituoituja pyridinyylijohdannaisia LPA1-reseptoriantagonisteina ja niiden käyttö fibroosin hoidossa
JP2008517945A5 (https=)
JP2016503009A5 (https=)
JP2014525444A5 (https=)
JP2016526576A5 (https=)
JP2009536197A5 (https=)
EP3022202A1 (en) Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
HRP20161011T1 (hr) Aril dihidropiridinoni i piperidinoni kao inhibitori mgat2
JP2015501799A5 (https=)
HRP20160539T1 (hr) Antagonisti trpv4
JP2009510043A5 (https=)
RU2006127572A (ru) Полигетероциклические соединения и их применение в качестве антагонистов метаботропного рецептора глутамата
JP2014521696A5 (https=)
JP2006506380A5 (https=)
JP2013527847A5 (https=)
JPWO2020262603A5 (https=)
HRP20240297T1 (hr) Derivati alfa-d-galaktopiranozida
JP2016540811A5 (https=)
HRP20161702T1 (hr) Novi derivati pirazina
JP2014513122A5 (https=)
HRP20241015T1 (hr) Derivati aminopiridina i njihova uporaba kao selektivnih alk-2 inhibitora
JPWO2020216766A5 (https=)